Azelastine Hydrochloride
NDC 61314-308, azelastine hydrochloride, solution/ drops, from Sandoz Inc.
- Product NDC
- 61314-308
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- SOLUTION/ DROPS
- Route
- INTRAOCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202305
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61314-308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELASTINE HYDROCHLORIDE.5 mg/mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61314-308-02 | 61314030802 | 1 BOTTLE, PLASTIC in 1 CARTON (61314-308-02) / 6 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6945fb86-27fb-4bab-8908-98772c6269c5NADAC price for package 61314030802
GET /v1/drugs/nadac/61314030802
Use it
Look up 61314-308 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61314-308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61314-308. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.